These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34095488)

  • 1. Hypercalcemia of Malignancy Attributed to Cosecretion of PTH and PTHRP in Lung Adenocarcinoma.
    Kroopnick JM; Martinez-Outschoorn U; Tuluc M; Kim CS
    AACE Clin Case Rep; 2021; 7(3):200-203. PubMed ID: 34095488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: a new treatment strategy with zoledronic acid and Denosumab.
    Kilci F; Demirsoy U; Jones JH; Çakır Ö; Çizmecioğlu-Jones FM
    J Pediatr Endocrinol Metab; 2022 Aug; 35(8):1107-1112. PubMed ID: 35534911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercalcemia in non-Hodgkin's lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D.
    Gonciulea AR; Wang Y; Bikle DD; Sellmeyer DE
    Osteoporos Int; 2021 Dec; 32(12):2587-2592. PubMed ID: 34230999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Diagnostic Workup and Etiology of Hypercalcemia of Malignancy in a Cohort of 167 551 Patients Over 20 Years.
    Sheehan MT; Li YH; Doi SA; Onitilo AA
    J Endocr Soc; 2021 Nov; 5(11):bvab157. PubMed ID: 34703961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitriol Elevation Is Associated with a Higher Risk of Refractory Hypercalcemia of Malignancy in Solid Tumors.
    Chukir T; Liu Y; Hoffman K; Bilezikian JP; Farooki A
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1115-23. PubMed ID: 31841590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
    Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
    J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia of malignancy in metastatic esophageal squamous cell carcinoma with simultaneous PTHrP and calcitriol overproduction: A case report with literature review.
    Song R; Bijay Y; Rizk SH; Cao S
    Ann Med Surg (Lond); 2021 Aug; 68():102667. PubMed ID: 34401137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumors (PTHrP-PNETs): Case Report.
    Pitts S; Mahipal A; Bajor D; Mohamed A
    Front Oncol; 2023; 13():1197288. PubMed ID: 37377908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical utility of parathyroid hormone-related peptide in the assessment of hypercalcemia.
    Fritchie K; Zedek D; Grenache DG
    Clin Chim Acta; 2009 Apr; 402(1-2):146-9. PubMed ID: 19168044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma.
    Rodríguez-Gutiérrez R; Zapata-Rivera MA; Quintanilla-Flores DL; Camara-Lemarroy CR; Lavalle-Gonzalez FJ; González-González JG; Villarreal-Pérez JZ
    BMC Endocr Disord; 2014 Apr; 14():32. PubMed ID: 24721620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung cancer associated with hypercalcemia induced by concurrently elevated parathyroid hormone and parathyroid hormone-related protein levels.
    Uchimura K; Mokuno T; Nagasaka A; Hayakawa N; Kato T; Yamazaki N; Kobayashi T; Nagata M; Kotake M; Itoh M; Tsujimura T; Iwase K
    Metabolism; 2002 Jul; 51(7):871-5. PubMed ID: 12077733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
    McMahan J; Linneman T
    Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Hypercalcemia from PTHrP-Producing Fibromyxoid Sarcoma Responsive to Glucocorticoid Therapy.
    Niu I; Hsiao EC; Wustrack R; Wysolmerski JJ; Dann P; Masharani U
    Calcif Tissue Int; 2023 Aug; 113(2):246-253. PubMed ID: 37358786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
    Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
    J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denosumab is Effective for Controlling Serum Calcium Levels in Patients with Humoral Hypercalcemia of Malignancy Syndrome: A Case Report on Parathyroid Hormone-related Protein-producing Cholangiocarcinoma.
    Ashihara N; Nakajima K; Nakamura Y; Kobayashi M; Shirahata K; Maeda C; Uehara T; Gomi D; Ito N
    Intern Med; 2016; 55(23):3453-3457. PubMed ID: 27904108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercalcemia of Malignancy and Colorectal Cancer.
    Galindo RJ; Romao I; Valsamis A; Weinerman S; Harris YT
    World J Oncol; 2016 Feb; 7(1):5-12. PubMed ID: 26998187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone/parathyroid hormone-related protein receptor expression in nude mice with a transplantable canine apocrine adenocarcinoma (CAC-8) and humoral hypercalcaemia of malignancy.
    Gröne A; McCauley LK; Capen CC; Rosol TJ
    J Endocrinol; 1997 Apr; 153(1):123-9. PubMed ID: 9135577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone-related protein, parathyroid hormone, and vitamin D in hypercalcemia of malignancy.
    Motellón JL; Javort Jiménez F; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
    Clin Chim Acta; 2000 Jan; 290(2):189-97. PubMed ID: 10660809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic Production of Parathyroid Hormone and Production of Parathyroid Hormone-related Protein in Dedifferentiated Endometrial Carcinoma Induced Severe Hypercalcemia.
    Ogino T; Watanabe H; Yamazaki S; Kurosawa M; Kobayashi A; Imai N; Taguchi T; Umezu H; Aida R; Watanabe K; Otsuka T; Kabasawa H; Kaseda R; Yamamoto S; Yoshihara K; Goto S; Narita I
    Intern Med; 2024 Sep; ():. PubMed ID: 39231677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation by plasma may be responsible for lack of efficacy of parathyroid hormone antagonists in hypercalcemia of malignancy.
    Kukreja SC; D'Anza JJ; Wimbiscus SA; Fisher JE; McKee RL; Caulfield MP; Rosenblatt M
    Endocrinology; 1994 May; 134(5):2184-8. PubMed ID: 8156920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.